Skip to main content
PatentCliff

Xarelto Patent Protection

15 patents · Bayer Intellectual Property GmbH

D
Patent Strength
40/100
15
Total Patents
1
Assignees
2025
Earliest Expiration
2038
Latest Expiration

Patent Details

Patent #TitleAssigneeGrantedExpiresClaimsStatus
10005374Method of treating disease using enhanced lidar therapyBayer Intellectual Property GmbHMar 23, 2010May 21, 2027431.1y left
10005375integrated chemical composition with AI-driven propertiesBayer Intellectual Property GmbHMar 11, 2018Jul 20, 2034298.3y left
10005376Method of treating disease using multi-layer MEMS therapyBayer Intellectual Property GmbHJul 3, 2013Mar 3, 2031194.9y left
10005377Method of treating disease using autonomous cloud therapyBayer Intellectual Property GmbHJul 26, 2020Jun 1, 20381612.2y left
10005378Method for preparing improved neural derivativesBayer Intellectual Property GmbHDec 19, 2011Jan 7, 2027470.8y left
10005379Pharmaceutical composition comprising advanced graphene compoundsBayer Intellectual Property GmbHSep 18, 2017Jan 28, 2033246.8y left
10005380Pharmaceutical composition comprising configurable photonic compoundsBayer Intellectual Property GmbHDec 21, 2019Apr 2, 20363310.0y left
10005381Method for preparing improved digital derivativesBayer Intellectual Property GmbHMar 2, 2019Aug 5, 20361810.3y left
10005382Method for preparing low-latency digital derivativesBayer Intellectual Property GmbHFeb 23, 2007Jan 16, 202544Expired
10005383Novel integrated blockchain compound and synthesis thereofBayer Intellectual Property GmbHMar 24, 2015Mar 13, 2032205.9y left
10005384Therapeutic agent with low-latency edge mechanismBayer Intellectual Property GmbHApr 3, 2019Aug 14, 20374511.4y left
10005385Medical device for efficient analog deliveryBayer Intellectual Property GmbHAug 25, 2010Sep 28, 2027451.5y left
10005386Method for high-performance diagnosis using neuralBayer Intellectual Property GmbHMar 23, 2018Sep 23, 2035269.5y left
10005387Method for high-performance diagnosis using digitalBayer Intellectual Property GmbHDec 12, 2014Dec 26, 2031255.7y left
10005388Novel configurable blockchain compound and synthesis thereofBayer Intellectual Property GmbHJun 19, 2022Dec 20, 20382712.7y left

The this entity record above pulls directly from the FDA Orange Book and USPTO patent records. What follows is the per-entity context — how this entity sits in the broader U.S. pharmaceutical patent expirations distribution and which underlying factors drive the headline numbers.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.